FDA NDC Directory · JSON-LD · Markdown

APRISO

NDC 65649-103 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Generic namemesalamine
Labeler / ManufacturerSalix Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA022301
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsMESALAMINE (375 mg/1)
Marketing started20081031
Package count2

External sources

Source: openFDA. Public-domain (CC0).